Results 191 to 200 of about 14,756 (228)
Some of the next articles are maybe not open access.
Autoimmune Bullous Diseases in Austria
Dermatologic Clinics, 2011Autoimmune bullous diseases (AIBD) are chronic disorders associated with significant morbidity and even mortality, for which the 19 dermatologic departments in Austria apply standard modalities to provide state-of-the-art diagnosis and treatment. Most of the affected individuals are initially treated on an inpatient basis, with follow-up done in ...
Martin, Laimer +6 more
openaire +2 more sources
Diagnosis of autoimmune bullous diseases
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2018SummaryAutoimmune bullous disorders (AIBDs) are a heterogeneous group of rare diseases clinically characterized by erosions and/or blisters on the skin and mucous membranes. AIBDs can be categorized into two groups: pemphigus diseases, characterized by intraepidermal blistering and autoantibodies against desmosomal proteins such as desmoglein (Dsg) 1 ...
Nina, van Beek +2 more
openaire +2 more sources
Oral involvement in autoimmune bullous diseases
Clinics in Dermatology, 2011The oral mucosa is frequently involved by autoimmune bullous diseases and often this is the first site of manifestation. In this site the lesions are very similar, making the clinical diagnosis difficult; therefore, the definition of the immunohistopathologic characteristics of each one becomes essential for a differential diagnosis. The authors review
Marcia, Ramos-e-Silva +2 more
openaire +2 more sources
Rituximab in refractory autoimmune bullous diseases
Clinical and Experimental Dermatology, 2006Treatment of autoimmune blistering diseases consists of systemic glucocorticosteroids usually in combination with additional immunosuppressants such as azathioprine and mycophenolate mofetil or immunomodulators such as dapsone, antibiotics, intravenous immunoglobulins, and immunoadsorption.
E, Schmidt +4 more
openaire +2 more sources
[Autoimmune bullous skin diseases].
La Revue de medecine interne, 1999Important advances have been made in the pathogenesis of autoimmune bullous skin diseases during the last 10 years. The aim of this review is to describe new types of autoimmune bullous skin diseases and to summarize progresses in the pathogenesis and treatment of these diseases.Paraneoplastic pemphigus (PNP) is a new type of pemphigus, distinct from ...
openaire +1 more source
Subepithelial autoimmune bullous dermatoses disease activity assessment and therapy
Journal of the American Academy of Dermatology, 2021Dedee Murrell +2 more
exaly
B cell depletion therapies in autoimmune disease: advances and mechanistic insights
Nature Reviews Drug Discovery, 2020Olga L Rojas, Jennifer L Gommerman
exaly